{
  "pmcid": "3528022",
  "sha256": "b0d1e58475265ff29ea68690c0cecd4743da66be00f95cb28182225d28151643",
  "timestamp_utc": "2025-11-09T15:53:00.857931+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.408114819759682,
    "reading_ease": 42.22206542056077,
    "word_count": 428
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "An as-treated analysis was performed on patients enrolled in the Spine Patient Outcomes Research Trial for the treatment of lumbar disc herniation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "A comparison was made between patients with a body mass index of <30 kg/m 2 (nonobese) (n = 854) and those with a body mass index of ≥30 kg/m 2 (obese) (n = 336)."
      },
      "Objective": {
        "score": 1,
        "evidence": "The purpose of this study was to determine if obesity affects outcomes following the treatment of symptomatic lumbar disc herniation."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Primary and secondary outcomes were measured at baseline and at regular follow-up time intervals up to four years."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A comparison was made between patients with a body mass index of <30 kg/m 2 (nonobese) (n = 854) and those with a body mass index of ≥30 kg/m 2 (obese) (n = 336)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "At the time of the four-year follow-up evaluation, improvements over baseline in primary outcome measures were significantly less for obese patients as compared with nonobese patients in both the operative treatment group (Short Form-36 physical function, 37.3 compared with 47.7 points [p < 0.001], Short Form-36 bodily pain, 44.2 compared with 50.0 points [p = 0.005], and Oswestry Disability Index, −33.7 compared with −40.1 points [p < 0.001]) and the nonoperative treatment group (Short Form-36 physical function, 23.1 compared with 32.0 points [p < 0.001] and Oswestry Disability Index, −21.4 compared with −26.1 points [p < 0.001])."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}